X
Celgene strikes $1.5bn cell therapy deal with Immatics
https://pharmaphorum.com/news/celgene-strikes-1-5bn-cell-therapy-deal-with-immatics/
Immatics
European biotech round-up: Ablynx’s big break and more
European biotech: a mixture of encouraging clinical trials and new funding lift the sector.
Amgen, Immatics strike $1bn cancer R&D deal
Companies to develop bispecific antibodies.